Telomerase in cancer and aging

Critical Reviews in Oncology/Hematology

Volumn 41, Issue 1, 2002, Pages 29-40

  Granger, Meaghan P ^a   Wright, Woodring E ^a   Shay, Jerry W ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Cancer; Immunosenescence; Replicative aging; Senescence; Telomerase; Telomerase inhibitors; Telomere

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; TELOMERASE; TELOMERASE INHIBITOR;

AGING; CANCER; CANCER GROWTH; CANCER IMMUNOTHERAPY; CELL DIVISION; CELL SURVIVAL; CHROMOSOME; GENETIC DISORDER; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HUMAN; HYPOTHESIS; LEUKOCYTE; MALIGNANT TRANSFORMATION; MINIMAL RESIDUAL DISEASE; PROGNOSIS; REVIEW; SENESCENCE; TELOMERE;

AGING; ANIMALS; ENZYME INHIBITORS; HUMANS; NEOPLASMS; PROGNOSIS; TELOMERASE; TELOMERE;

EID: 0036143843     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(01)00188-3     Document Type: Review

References (67)

1. Role of telomerase in normal and cancer cells
2. A highly conserved repetitive DNA sequence (TTAGGG)n, present at the telomeres of human chromosomes
3. Cell proliferation, carcinogenesis, and diverse mechanisms of telomerase regulation
4. Telomeres shorten during ageing of human fibroblasts
5. Hayflick, his limit, and cellular ageing
6. Telomeres and telomerase: more than the end of the line
7. Mammalian telomeres end in a large duplex loop
8. Telomeres and telomerase in the regulation of human cellular aging
9. At the end of the millennium, a view of the end
10. Identification of human Rap1p: implications for telomere evolution
11. The DNA damage response: putting checkpoints in perspective
12. Cell-cycle regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres
13. Role of telomerase in cellular proliferation and cancer
14. Telomerases
15. Cellular senescence as a tumor-protection mechanism: the essential role of counting
16. Functional requirement of p23 and hsp90 in telomerase complexes
17. Implications of mapping the human telomerase gene (hTERT) as the most distal gene on chromosome 5p
18. Telomere positional effects and the regulation of cellular senescence
19. Telomere position effect in human cells
20. Putative telomere-independent mechanisms of replicative aging eflect inadequate growth conditions
21. Transient expression of human telomerase extends the lifespan of normal human fibroblasts
22. Inhibition of telomerase in immortalized human cells leads to progressive telomere shortening and cell death
23. Extension of life-span by introduction of telomerase into normal human cells
24. Telomere maintenance by recombination in human cells
25. Replicative senescence: an old lives' tale?
26. The establishment of telomerase-immortalized cell lines representing human chromosome instability syndromes
27. Accelerated telomere shortening in bone-marrow recipients
28. Telomeres and telomerase in human leukemias
29. Accelerated telomere shortening in young recipients of allogeneic bone marrow transplants
30. Telomerase activity and telomere length in the hematopoietic system: changes with aging, disease, and therapy
31. Ageing of lymphocytes and lymphocytes in the aged
32. The role of telomerase expression and telomere length maintenance in human and mouse
33. Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation
34. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening
35. Replicative senescence in the immune system: impact of the hayflick limit of T-cell function in the elderly
36. Telomerase activity in normal and malignant hematopoietic cells
37. A survey of telomerase activity in human cancer
38. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia
39. Telomerase activity in plasma cell dyscrasias
40. Telomerase activity in Hodgkin's disease
41. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase
42. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype
43. Creation of human tumor cells with defined genetic elements
44. The hallmarks of cancer
45. The reactivation of telomerase activity in cancer progression
46. Evaluation of telomerase activity in cutaneous melanocytic proliferations
47. Telomerase in cancer: diagnostic, prognostic, and therapeutic implications
48. Telomerase activity and survival of patients with node-positive breast cancer
49. Telomerase activity in human breast tumours
50. Telomerase and breast cancer
51. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal carcinoma
52. Telomerase activity: a prognostic indicator in ordinary meningiomas
53. Quantitative telomerase expression in glioblastomas shows regional variation and down-regulation with therapy but no correlation with patient outcome
54. Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples
55. Telomerase in the early detection of cancer
56. Telomerase inhibitors
57. Inhibition of telomerase limits the growth of human cancer cells
58. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes
59. Cytotoxic T cell immunity against telomerase reverse transcriptase in humans
60. Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells